Cargando…
Peptide-based PET imaging of the tumor restricted IL13RA2 biomarker
Peptides that target cancer cell surface receptors are promising platforms to deliver diagnostic and therapeutic payloads specifically to cancer but not normal tissue. IL13RA2 is a tumor-restricted receptor found to be present in several aggressive malignancies, including in the vast majority of hig...
Autores principales: | Sai, Kiran Kumar Solingapuram, Sattiraju, Anirudh, Almaguel, Frankis G., Xuan, Ang, Rideout, Stephanie, Krishnaswamy, Rahul S., Zhang, JoAnn, Herpai, Denise M., Debinski, Waldemar, Mintz, Akiva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584224/ https://www.ncbi.nlm.nih.gov/pubmed/28881623 http://dx.doi.org/10.18632/oncotarget.16549 |
Ejemplares similares
-
IL13RA2 targeted alpha particle therapy against glioblastomas
por: Sattiraju, Anirudh, et al.
Publicado: (2017) -
Novel Peripherally Derived Neural‐Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas
por: Birbrair, Alexander, et al.
Publicado: (2016) -
Improved Automated Radiosynthesis of [(11)C]PBR28
por: Solingapuram Sai, Kiran Kumar, et al.
Publicado: (2015) -
Binding Parameters of [(11)C]MPC-6827, a Microtubule-Imaging PET Radiopharmaceutical in Rodents
por: Bansode, Avinash H., et al.
Publicado: (2023) -
Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas
por: Rossmeisl, John H, et al.
Publicado: (2020)